Six-month safety follow-up of an adjuvanted SARS-CoV-2 trimeric S-protein subunit vaccine (SCB-2019) in adults: A phase 2/3, double-blind, randomized study.
Vaccine（2023）
摘要
NCT04672395; EudraCT: 2020-004272-17.
更多查看译文
关键词
COVID-19,Recombinant,SARS-CoV-2,SCB-2019,Safety,Vaccine
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要